25 XP   0   0   10

Sihuan Pharmaceutical Holdings Group Ltd
Buy, Hold or Sell?

Let's analyse Sihuan Pharmaceutical Holdings Group Ltd together

PenkeI guess you are interested in Sihuan Pharmaceutical Holdings Group Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Sihuan Pharmaceutical Holdings Group Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Sihuan Pharmaceutical Holdings Group Ltd

I send you an email if I find something interesting about Sihuan Pharmaceutical Holdings Group Ltd.

Quick analysis of Sihuan Pharmaceutical Holdings Group Ltd (30 sec.)










What can you expect buying and holding a share of Sihuan Pharmaceutical Holdings Group Ltd? (30 sec.)

How much money do you get?

How much money do you get?
HK$0.01
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
HK$0.55
Expected worth in 1 year
HK$-1.10
How sure are you?
70.0%

+ What do you gain per year?

Total Gains per Share
HK$-1.59
Return On Investment
-278.1%

For what price can you sell your share?

Current Price per Share
HK$0.57
Expected price per share
HK$0.55 - HK$0.59
How sure are you?
50%

1. Valuation of Sihuan Pharmaceutical Holdings Group Ltd (5 min.)




Live pricePrice per Share (EOD)

HK$0.57

Intrinsic Value Per Share

HK$-1.96 - HK$0.22

Total Value Per Share

HK$-1.41 - HK$0.77

2. Growth of Sihuan Pharmaceutical Holdings Group Ltd (5 min.)




Is Sihuan Pharmaceutical Holdings Group Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$655m$1.1b-$490.5m-74.9%

How much money is Sihuan Pharmaceutical Holdings Group Ltd making?

Current yearPrevious yearGrowGrow %
Making money-$264.8m$57.6m-$322.4m-121.8%
Net Profit Margin-87.8%12.7%--

How much money comes from the company's main activities?

3. Financial Health of Sihuan Pharmaceutical Holdings Group Ltd (5 min.)




What can you expect buying and holding a share of Sihuan Pharmaceutical Holdings Group Ltd? (5 min.)

Welcome investor! Sihuan Pharmaceutical Holdings Group Ltd's management wants to use your money to grow the business. In return you get a share of Sihuan Pharmaceutical Holdings Group Ltd.

What can you expect buying and holding a share of Sihuan Pharmaceutical Holdings Group Ltd?

First you should know what it really means to hold a share of Sihuan Pharmaceutical Holdings Group Ltd. And how you can make/lose money.

Speculation

The Price per Share of Sihuan Pharmaceutical Holdings Group Ltd is HK$0.57. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Sihuan Pharmaceutical Holdings Group Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Sihuan Pharmaceutical Holdings Group Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is HK$0.55. Based on the TTM, the Book Value Change Per Share is HK$-0.41 per quarter. Based on the YOY, the Book Value Change Per Share is HK$-0.18 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is HK$0.02 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Sihuan Pharmaceutical Holdings Group Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 HK$% of Price per ShareHK$% of Price per ShareHK$% of Price per ShareHK$% of Price per ShareHK$% of Price per Share
Usd Eps-0.03-5.0%-0.03-5.0%0.011.1%-0.01-1.1%0.011.4%
Usd Book Value Change Per Share-0.05-9.2%-0.05-9.2%-0.02-4.0%-0.02-3.3%0.00-0.5%
Usd Dividend Per Share0.000.3%0.000.3%0.000.3%0.011.1%0.011.2%
Usd Total Gains Per Share-0.05-8.9%-0.05-8.9%-0.02-3.6%-0.01-2.2%0.000.8%
Usd Price Per Share0.12-0.12-0.19-0.14-0.35-
Price to Earnings Ratio-4.28--4.28-30.64-9.19-17.70-
Price-to-Total Gains Ratio-2.40--2.40--9.12--0.51-14.23-
Price to Book Ratio1.73-1.73-1.54-1.15-2.73-
Price-to-Total Gains Ratio-2.40--2.40--9.12--0.51-14.23-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.072846
Number of shares13727
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.01
Usd Book Value Change Per Share-0.05-0.02
Usd Total Gains Per Share-0.05-0.01
Gains per Quarter (13727 shares)-695.15-175.82
Gains per Year (13727 shares)-2,780.59-703.29
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1106-2887-2791343-1047-713
2213-5774-5572687-2093-1416
3319-8661-83531030-3140-2119
4425-11548-111341374-4187-2822
5532-14435-139151717-5233-3525
6638-17321-166962060-6280-4228
7744-20208-194772404-7327-4931
8850-23095-222582747-8373-5634
9957-25982-250393090-9420-6337
101063-28869-278203434-10467-7040

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%2.01.00.066.7%3.02.00.060.0%8.02.00.080.0%15.02.03.075.0%
Book Value Change Per Share0.01.00.00.0%1.02.00.033.3%2.03.00.040.0%7.03.00.070.0%17.03.00.085.0%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%15.00.05.075.0%
Total Gains per Share0.01.00.00.0%1.02.00.033.3%2.03.00.040.0%7.03.00.070.0%17.03.00.085.0%

Fundamentals of Sihuan Pharmaceutical Holdings Group Ltd

About Sihuan Pharmaceutical Holdings Group Ltd

Sihuan Pharmaceutical Holdings Group Ltd., an investment holding company, engages in the research and development, manufacture, marketing, and sale of pharmaceutical and medical aesthetic products in the People's Republic of China. It offers drugs in the oncology, metabolism, diabetes, cardiovascular and cerebrovascular, modern Chinese medicine, and industrial hemp therapeutic areas. The company is also involved in the investment and sale of medical beauty products; manufacture of medical instruments; investment in properties; construction for medical projects; and project preparation for pharmaceutical products manufacturing. In addition, it provides information support, general hospital, hospital management, biotechnology and technology promotion, and medical aesthetic research and development services. Sihuan Pharmaceutical Holdings Group Ltd. was founded in 2001 and is based in Wan Chai, Hong Kong.

Fundamental data was last updated by Penke on 2024-03-24 17:27:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is just able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Sihuan Pharmaceutical Holdings Group Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Sihuan Pharmaceutical Holdings Group Ltd earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Sihuan Pharmaceutical Holdings Group Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of -87.8% means that $-0.88 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Sihuan Pharmaceutical Holdings Group Ltd:

  • The MRQ is -87.8%. The company is making a huge loss. -2
  • The TTM is -87.8%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-87.8%TTM-87.8%0.0%
TTM-87.8%YOY12.7%-100.4%
TTM-87.8%5Y-19.2%-68.6%
5Y-19.2%10Y15.7%-34.9%
1.1.2. Return on Assets

Shows how efficient Sihuan Pharmaceutical Holdings Group Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Sihuan Pharmaceutical Holdings Group Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • -15.8% Return on Assets means that Sihuan Pharmaceutical Holdings Group Ltd generated $-0.16 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Sihuan Pharmaceutical Holdings Group Ltd:

  • The MRQ is -15.8%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -15.8%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-15.8%TTM-15.8%0.0%
TTM-15.8%YOY2.9%-18.6%
TTM-15.8%5Y-4.1%-11.6%
5Y-4.1%10Y4.9%-9.0%
1.1.3. Return on Equity

Shows how efficient Sihuan Pharmaceutical Holdings Group Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Sihuan Pharmaceutical Holdings Group Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • -40.4% Return on Equity means Sihuan Pharmaceutical Holdings Group Ltd generated $-0.40 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Sihuan Pharmaceutical Holdings Group Ltd:

  • The MRQ is -40.4%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -40.4%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-40.4%TTM-40.4%0.0%
TTM-40.4%YOY5.0%-45.5%
TTM-40.4%5Y-9.2%-31.2%
5Y-9.2%10Y3.6%-12.8%

1.2. Operating Efficiency of Sihuan Pharmaceutical Holdings Group Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Sihuan Pharmaceutical Holdings Group Ltd is operating .

  • Measures how much profit Sihuan Pharmaceutical Holdings Group Ltd makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Sihuan Pharmaceutical Holdings Group Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of -24.6% means the company generated $-0.25  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Sihuan Pharmaceutical Holdings Group Ltd:

  • The MRQ is -24.6%. The company is operating very inefficient. -2
  • The TTM is -24.6%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-24.6%TTM-24.6%0.0%
TTM-24.6%YOY20.5%-45.1%
TTM-24.6%5Y25.9%-50.5%
5Y25.9%10Y39.6%-13.7%
1.2.2. Operating Ratio

Measures how efficient Sihuan Pharmaceutical Holdings Group Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.57 means that the operating costs are $1.57 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Sihuan Pharmaceutical Holdings Group Ltd:

  • The MRQ is 1.572. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.572. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.572TTM1.5720.000
TTM1.572YOY1.062+0.510
TTM1.5725Y1.002+0.570
5Y1.00210Y0.826+0.176

1.3. Liquidity of Sihuan Pharmaceutical Holdings Group Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Sihuan Pharmaceutical Holdings Group Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 2.59 means the company has $2.59 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Sihuan Pharmaceutical Holdings Group Ltd:

  • The MRQ is 2.586. The company is able to pay all its short-term debts. +1
  • The TTM is 2.586. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.586TTM2.5860.000
TTM2.586YOY3.094-0.508
TTM2.5865Y2.732-0.146
5Y2.73210Y3.319-0.587
1.3.2. Quick Ratio

Measures if Sihuan Pharmaceutical Holdings Group Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Sihuan Pharmaceutical Holdings Group Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 2.91 means the company can pay off $2.91 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Sihuan Pharmaceutical Holdings Group Ltd:

  • The MRQ is 2.909. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 2.909. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ2.909TTM2.9090.000
TTM2.909YOY2.602+0.307
TTM2.9095Y2.718+0.192
5Y2.71810Y2.938-0.220

1.4. Solvency of Sihuan Pharmaceutical Holdings Group Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Sihuan Pharmaceutical Holdings Group Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Sihuan Pharmaceutical Holdings Group Ltd to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.61 means that Sihuan Pharmaceutical Holdings Group Ltd assets are financed with 61.0% credit (debt) and the remaining percentage (100% - 61.0%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Sihuan Pharmaceutical Holdings Group Ltd:

  • The MRQ is 0.610. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.610. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.610TTM0.6100.000
TTM0.610YOY0.429+0.181
TTM0.6105Y0.332+0.278
5Y0.33210Y0.239+0.093
1.4.2. Debt to Equity Ratio

Measures if Sihuan Pharmaceutical Holdings Group Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Sihuan Pharmaceutical Holdings Group Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 156.3% means that company has $1.56 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Sihuan Pharmaceutical Holdings Group Ltd:

  • The MRQ is 1.563. The company is just able to pay all its debts with equity.
  • The TTM is 1.563. The company is just able to pay all its debts with equity.
Trends
Current periodCompared to+/- 
MRQ1.563TTM1.5630.000
TTM1.563YOY0.750+0.813
TTM1.5635Y0.627+0.936
5Y0.62710Y0.402+0.226

2. Market Valuation of Sihuan Pharmaceutical Holdings Group Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Sihuan Pharmaceutical Holdings Group Ltd generates.

  • Above 15 is considered overpriced but always compare Sihuan Pharmaceutical Holdings Group Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of -4.28 means the investor is paying $-4.28 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Sihuan Pharmaceutical Holdings Group Ltd:

  • The EOD is -2.566. Based on the earnings, the company is expensive. -2
  • The MRQ is -4.277. Based on the earnings, the company is expensive. -2
  • The TTM is -4.277. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-2.566MRQ-4.277+1.711
MRQ-4.277TTM-4.2770.000
TTM-4.277YOY30.637-34.915
TTM-4.2775Y9.192-13.469
5Y9.19210Y17.698-8.506
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Sihuan Pharmaceutical Holdings Group Ltd:

  • The EOD is -8.977. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -14.962. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -14.962. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-8.977MRQ-14.962+5.985
MRQ-14.962TTM-14.9620.000
TTM-14.962YOY-124.939+109.976
TTM-14.9625Y-28.223+13.261
5Y-28.22310Y17.899-46.122
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Sihuan Pharmaceutical Holdings Group Ltd is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Sihuan Pharmaceutical Holdings Group Ltd:

  • The EOD is 1.037. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.729. Based on the equity, the company is underpriced. +1
  • The TTM is 1.729. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.037MRQ1.729-0.692
MRQ1.729TTM1.7290.000
TTM1.729YOY1.540+0.189
TTM1.7295Y1.149+0.580
5Y1.14910Y2.729-1.579
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Sihuan Pharmaceutical Holdings Group Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.411-0.4110%-0.177-57%-0.149-64%-0.020-95%
Book Value Per Share--0.5490.5490%0.961-43%1.049-48%1.070-49%
Current Ratio--2.5862.5860%3.094-16%2.732-5%3.319-22%
Debt To Asset Ratio--0.6100.6100%0.429+42%0.332+84%0.239+156%
Debt To Equity Ratio--1.5631.5630%0.750+108%0.627+149%0.402+289%
Dividend Per Share--0.0150.0150%0.014+6%0.049-69%0.055-72%
Eps---0.222-0.2220%0.048-560%-0.050-78%0.062-456%
Free Cash Flow Per Share---0.063-0.0630%-0.012-81%0.027-339%0.072-189%
Free Cash Flow To Equity Per Share---0.091-0.0910%0.075-221%0.036-355%0.022-520%
Gross Profit Margin--1.0001.0000%1.0000%0.829+21%0.695+44%
Intrinsic Value_10Y_max--0.220--------
Intrinsic Value_10Y_min---1.962--------
Intrinsic Value_1Y_max--0.061--------
Intrinsic Value_1Y_min---0.079--------
Intrinsic Value_3Y_max--0.154--------
Intrinsic Value_3Y_min---0.341--------
Intrinsic Value_5Y_max--0.210--------
Intrinsic Value_5Y_min---0.714--------
Market Cap5318099927.040-67%8863499878.4008863499878.4000%13808399810.560-36%10442445105.792-15%27349995543.896-68%
Net Profit Margin---0.878-0.8780%0.127-794%-0.192-78%0.157-658%
Operating Margin---0.246-0.2460%0.205-220%0.259-195%0.396-162%
Operating Ratio--1.5721.5720%1.062+48%1.002+57%0.826+90%
Pb Ratio1.037-67%1.7291.7290%1.540+12%1.149+50%2.729-37%
Pe Ratio-2.566+40%-4.277-4.2770%30.637-114%9.192-147%17.698-124%
Price Per Share0.570-67%0.9500.9500%1.480-36%1.110-14%2.720-65%
Price To Free Cash Flow Ratio-8.977+40%-14.962-14.9620%-124.939+735%-28.223+89%17.899-184%
Price To Total Gains Ratio-1.438+40%-2.397-2.3970%-9.121+280%-0.506-79%14.226-117%
Quick Ratio--2.9092.9090%2.602+12%2.718+7%2.938-1%
Return On Assets---0.158-0.1580%0.029-649%-0.041-74%0.049-425%
Return On Equity---0.404-0.4040%0.050-904%-0.092-77%0.036-1225%
Total Gains Per Share---0.396-0.3960%-0.162-59%-0.100-75%0.035-1241%
Usd Book Value--655090727.475655090727.4750%1145634543.192-43%1263616972.364-48%1335754011.666-51%
Usd Book Value Change Per Share---0.053-0.0530%-0.023-57%-0.019-64%-0.003-95%
Usd Book Value Per Share--0.0700.0700%0.123-43%0.134-48%0.137-49%
Usd Dividend Per Share--0.0020.0020%0.002+6%0.006-69%0.007-72%
Usd Eps---0.028-0.0280%0.006-560%-0.006-78%0.008-456%
Usd Free Cash Flow---75707333.677-75707333.6770%-14124630.524-81%32431554.520-333%91000769.908-183%
Usd Free Cash Flow Per Share---0.008-0.0080%-0.002-81%0.003-339%0.009-189%
Usd Free Cash Flow To Equity Per Share---0.012-0.0120%0.010-221%0.005-355%0.003-520%
Usd Market Cap679653170.676-67%1132755284.4601132755284.4600%1764713495.790-36%1334544484.520-15%3495329430.510-68%
Usd Price Per Share0.073-67%0.1210.1210%0.189-36%0.142-14%0.348-65%
Usd Profit---264818567.725-264818567.7250%57600020.901-560%-59698137.574-77%83465563.853-417%
Usd Revenue--301641818.040301641818.0400%455157561.523-34%380057027.151-21%423959132.496-29%
Usd Total Gains Per Share---0.051-0.0510%-0.021-59%-0.013-75%0.004-1241%
 EOD+3 -5MRQTTM+0 -0YOY+6 -295Y+4 -3210Y+5 -31

3.2. Fundamental Score

Let's check the fundamental score of Sihuan Pharmaceutical Holdings Group Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-2.566
Price to Book Ratio (EOD)Between0-11.037
Net Profit Margin (MRQ)Greater than0-0.878
Operating Margin (MRQ)Greater than0-0.246
Quick Ratio (MRQ)Greater than12.909
Current Ratio (MRQ)Greater than12.586
Debt to Asset Ratio (MRQ)Less than10.610
Debt to Equity Ratio (MRQ)Less than11.563
Return on Equity (MRQ)Greater than0.15-0.404
Return on Assets (MRQ)Greater than0.05-0.158
Total3/10 (30.0%)

3.3. Technical Score

Let's check the technical score of Sihuan Pharmaceutical Holdings Group Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5049.725
Ma 20Greater thanMa 500.571
Ma 50Greater thanMa 1000.564
Ma 100Greater thanMa 2000.609
OpenGreater thanClose0.560
Total1/5 (20.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2018-12-312019-12-312020-12-312021-12-312022-12-31
EBIT  1,807,776-398,6711,409,105-580,385828,720-97,007731,713-1,311,750-580,037
EBITDA  2,140,241-347,3181,792,923-1,136,680656,243333,583989,826-2,658,202-1,668,376
Operating Income  1,807,776-398,6711,409,105-923,386485,719340,942826,661-2,807,690-1,981,030
Net Interest Income  171,5116,901178,411-40,432137,980-89,67848,302-117,969-69,668
Discontinued Operations  -47,5780-47,5789,794-37,78426,829-10,95550,23139,276



Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in CNY. All numbers in thousands.

Summary
Total Assets12,140,551
Total Liabilities7,403,553
Total Stockholder Equity4,736,998
 As reported
Total Liabilities 7,403,553
Total Stockholder Equity+ 4,736,998
Total Assets = 12,140,551

Assets

Total Assets12,140,551
Total Current Assets6,550,386
Long-term Assets5,590,165
Total Current Assets
Cash And Cash Equivalents 2,664,842
Short-term Investments 2,127,009
Net Receivables 449,970
Inventory 606,700
Other Current Assets 33,207
Total Current Assets  (as reported)6,550,386
Total Current Assets  (calculated)5,881,728
+/- 668,658
Long-term Assets
Property Plant Equipment 2,998,326
Goodwill 1,853
Intangible Assets 626,462
Long-term Assets Other 594,359
Long-term Assets  (as reported)5,590,165
Long-term Assets  (calculated)4,221,000
+/- 1,369,165

Liabilities & Shareholders' Equity

Total Current Liabilities2,533,000
Long-term Liabilities3,967,725
Total Stockholder Equity4,736,998
Total Current Liabilities
Short-term Debt 25,803
Short Long Term Debt 349,086
Accounts payable 205,782
Other Current Liabilities 1,264,868
Total Current Liabilities  (as reported)2,533,000
Total Current Liabilities  (calculated)1,845,539
+/- 687,461
Long-term Liabilities
Long term Debt Total 928,610
Capital Lease Obligations 59,040
Long-term Liabilities Other 2,804,261
Long-term Liabilities  (as reported)3,967,725
Long-term Liabilities  (calculated)3,791,911
+/- 175,814
Total Stockholder Equity
Common Stock77,058
Retained Earnings 1,691,491
Capital Surplus 3,882,304
Other Stockholders Equity -913,855
Total Stockholder Equity (as reported)4,736,998
Total Stockholder Equity (calculated)4,736,998
+/-0
Other
Capital Stock77,058
Cash And Equivalents3,828,863
Cash and Short Term Investments 4,791,851
Common Stock Shares Outstanding 9,329,999
Liabilities and Stockholders Equity 12,140,551
Net Invested Capital 5,968,838
Net Working Capital 4,017,386
Property Plant and Equipment Gross 6,144,684



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-31
> Total Assets 
59,552
83,617
150,891
198,231
630,546
862,051
1,173,442
6,902,452
8,854,098
9,459,444
10,011,648
11,322,983
12,321,007
12,187,604
13,591,863
15,443,475
12,571,436
13,043,926
14,495,623
12,140,551
12,140,55114,495,62313,043,92612,571,43615,443,47513,591,86312,187,60412,321,00711,322,98310,011,6489,459,4448,854,0986,902,4521,173,442862,051630,546198,231150,89183,61759,552
   > Total Current Assets 
0
0
0
67,218
310,047
441,997
796,958
6,164,645
5,073,879
4,020,980
5,162,906
5,626,496
5,446,945
5,194,973
4,774,324
5,776,419
6,305,147
6,404,153
7,741,455
6,550,386
6,550,3867,741,4556,404,1536,305,1475,776,4194,774,3245,194,9735,446,9455,626,4965,162,9064,020,9805,073,8796,164,645796,958441,997310,04767,218000
       Cash And Cash Equivalents 
7,106
7,560
17,524
41,788
262,380
331,178
612,859
5,851,379
3,153,154
1,543,907
1,508,076
1,317,945
2,282,370
2,407,073
831,859
3,314,845
5,117,143
4,604,041
5,682,425
2,664,842
2,664,8425,682,4254,604,0415,117,1433,314,845831,8592,407,0732,282,3701,317,9451,508,0761,543,9073,153,1545,851,379612,859331,178262,38041,78817,5247,5607,106
       Short-term Investments 
0
0
0
0
0
40,132
42,850
126,277
913,411
1,616,481
1,009,725
1,617,631
1,959,280
1,709,964
2,967,354
1,303,276
148,336
332,683
109,304
2,127,009
2,127,009109,304332,683148,3361,303,2762,967,3541,709,9641,959,2801,617,6311,009,7251,616,481913,411126,27742,85040,13200000
       Net Receivables 
17,805
22,398
31,090
10,769
18,425
4,090
34,404
27,763
530,143
679,285
1,105,999
881,973
808,575
704,852
634,547
739,928
513,191
820,922
607,850
449,970
449,970607,850820,922513,191739,928634,547704,852808,575881,9731,105,999679,285530,14327,76334,4044,09018,42510,76931,09022,39817,805
       Inventory 
1,732
3,584
9,038
7,180
22,953
39,395
42,967
53,346
57,653
91,472
101,283
177,181
233,028
200,680
227,970
301,117
409,595
495,889
715,298
606,700
606,700715,298495,889409,595301,117227,970200,680233,028177,181101,28391,47257,65353,34642,96739,39522,9537,1809,0383,5841,732
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
6,992,631
8,817,539
9,667,056
6,266,289
6,639,773
6,754,168
5,590,165
5,590,1656,754,1686,639,7736,266,2899,667,0568,817,5396,992,6310000000000000
       Property Plant Equipment 
2,172
2,824
43,228
52,992
78,675
117,287
162,036
253,153
419,258
924,052
1,441,677
1,704,128
2,051,370
2,104,299
2,453,594
2,775,371
2,740,349
3,841,261
4,092,702
2,998,326
2,998,3264,092,7023,841,2612,740,3492,775,3712,453,5942,104,2992,051,3701,704,1281,441,677924,052419,258253,153162,036117,28778,67552,99243,2282,8242,172
       Goodwill 
0
0
294
294
12,130
49,107
13,990
15,933
2,608,845
2,707,435
2,226,936
2,226,936
2,247,728
2,247,728
2,843,903
2,843,903
0
12,312
28,352
1,853
1,85328,35212,31202,843,9032,843,9032,247,7282,247,7282,226,9362,226,9362,707,4352,608,84515,93313,99049,10712,13029429400
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
34,069
358,491
1,189,118
1,292,851
1,051,167
1,350,406
1,258,078
0
0
0
0001,258,0781,350,4061,051,1671,292,8511,189,118358,49134,0690000000000
       Intangible Assets 
800
12,670
17,964
77,727
184,694
192,518
142,314
155,250
3,169,059
1,027,595
653,686
588,775
569,337
578,998
1,338,006
1,252,251
480,008
505,621
595,916
626,462
626,462595,916505,621480,0081,252,2511,338,006578,998569,337588,775653,6861,027,5953,169,059155,250142,314192,518184,69477,72717,96412,670800
       Long-term Assets Other 
0
0
0
0
45,000
0
0
236,199
97,668
122,521
0
296,317
171,075
56,000
100,000
275,615
338,614
367,869
0
594,359
594,3590367,869338,614275,615100,00056,000171,075296,3170122,52197,668236,1990045,0000000
> Total Liabilities 
35,259
36,997
65,051
47,781
105,733
146,191
249,255
242,923
1,860,155
2,272,189
2,013,858
1,916,970
1,129,275
1,216,511
2,255,793
2,669,112
2,629,242
3,095,201
6,211,475
7,403,553
7,403,5536,211,4753,095,2012,629,2422,669,1122,255,7931,216,5111,129,2751,916,9702,013,8582,272,1891,860,155242,923249,255146,191105,73347,78165,05136,99735,259
   > Total Current Liabilities 
35,259
36,997
52,309
35,098
95,519
127,194
219,260
233,397
1,741,142
1,850,370
1,803,889
1,693,168
933,899
1,038,493
1,903,313
2,248,619
2,260,780
2,443,086
2,501,835
2,533,000
2,533,0002,501,8352,443,0862,260,7802,248,6191,903,3131,038,493933,8991,693,1681,803,8891,850,3701,741,142233,397219,260127,19495,51935,09852,30936,99735,259
       Short-term Debt 
0
0
0
4,000
12,000
0
0
0
0
767,234
180,800
3,500
8,280
8,280
0
0
0
391,930
30,000
25,803
25,80330,000391,9300008,2808,2803,500180,800767,234000012,0004,000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
186,680
3,500
8,280
8,280
0
0
0
391,930
200,000
349,086
349,086200,000391,9300008,2808,2803,500186,6800000000000
       Accounts payable 
207
183
3,589
2,272
8,589
4,187
12,675
31,261
29,223
36,207
36,555
40,818
77,105
82,662
34,320
37,202
65,719
106,201
118,906
205,782
205,782118,906106,20165,71937,20234,32082,66277,10540,81836,55536,20729,22331,26112,6754,1878,5892,2723,589183207
       Other Current Liabilities 
16,052
17,814
26,720
28,826
74,930
123,007
206,585
202,136
1,711,919
1,046,929
1,586,534
1,652,350
786,577
784,878
1,129,520
1,192,993
982,281
957,428
1,100,458
1,264,868
1,264,8681,100,458957,428982,2811,192,9931,129,520784,878786,5771,652,3501,586,5341,046,9291,711,919202,136206,585123,00774,93028,82626,72017,81416,052
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
178,018
352,480
420,493
368,462
652,115
2,843,722
3,967,725
3,967,7252,843,722652,115368,462420,493352,480178,0180000000000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
95,000
14,892
361,683
844,679
928,610
928,610844,679361,68314,89295,000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
207,407
63,227
89,912
187,096
178,018
352,480
325,493
353,570
290,432
1,967,513
0
01,967,513290,432353,570325,493352,480178,018187,09689,91263,227207,407000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
248,580
225,287
215,693
283,726
1,084,274
1,002,291
194,777
194,701
164,299
0
0164,299194,701194,7771,002,2911,084,274283,726215,693225,287248,5800000000000
> Total Stockholder Equity
24,051
46,298
85,540
147,789
524,813
701,216
907,503
6,656,931
6,945,534
7,084,328
7,882,305
9,291,677
11,095,639
10,901,438
11,056,992
12,510,413
9,606,684
9,190,342
8,284,148
4,736,998
4,736,9988,284,1489,190,3429,606,68412,510,41311,056,99210,901,43811,095,6399,291,6777,882,3057,084,3286,945,5346,656,931907,503701,216524,813147,78985,54046,29824,051
   Retained Earnings 
0
0
25,896
68,601
227,016
373,790
545,747
891,582
6,945,534
1,400,702
2,174,606
3,479,322
5,262,640
6,340,925
6,719,232
8,179,232
5,250,978
4,302,088
4,921,939
1,691,491
1,691,4914,921,9394,302,0885,250,9788,179,2326,719,2326,340,9255,262,6403,479,3222,174,6061,400,7026,945,534891,582545,747373,790227,01668,60125,89600
   Accumulated Other Comprehensive Income 000-1,335,855-942,011-744,832-607,116-435,385-314,677-237,154-217,462-145,414-63,555-47,443-18,529-10,199-5,237000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
4,344,229
4,093,317
4,093,317
4,084,846
4,084,846
3,882,304
3,882,304
3,882,3043,882,3044,084,8464,084,8464,093,3174,093,3174,344,2290000000000000
   Treasury Stock000000-2550000000000000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2022-12-31)

Gross Profit (+$)
totalRevenue2,181,189
Cost of Revenue-693,608
Gross Profit1,487,5811,487,581
 
Operating Income (+$)
Gross Profit1,487,581
Operating Expense-2,735,397
Operating Income-1,830,727-1,247,816
 
Operating Expense (+$)
Research Development936,581
Selling General Administrative1,023,336
Selling And Marketing Expenses0
Operating Expense2,735,3971,959,917
 
Net Interest Income (+$)
Interest Income292,051
Interest Expense-228,027
Other Finance Cost-128,406
Net Interest Income-64,382
 
Pretax Income (+$)
Operating Income-1,830,727
Net Interest Income-64,382
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-2,122,778-1,830,727
EBIT - interestExpense = -764,056
-1,718,124
-1,686,891
Interest Expense228,027
Earnings Before Interest and Taxes (EBIT)-536,029-1,894,751
Earnings Before Interest and Taxes (EBITDA)-1,541,795
 
After tax Income (+$)
Income Before Tax-2,122,778
Tax Provision-196,794
Net Income From Continuing Ops-2,319,572-2,319,572
Net Income-1,914,918
Net Income Applicable To Common Shares-1,914,918
 
Non-recurring Events
Discontinued Operations36,296
Extraordinary Items36,296
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses63,693
Total Other Income/Expenses Net064,382
 

Technical Analysis of Sihuan Pharmaceutical Holdings Group Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Sihuan Pharmaceutical Holdings Group Ltd. The general trend of Sihuan Pharmaceutical Holdings Group Ltd is BEARISH with 71.4% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Sihuan Pharmaceutical Holdings Group Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-71.4%) Bearish trend (71.4%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Sihuan Pharmaceutical Holdings Group Ltd.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 0.59 < 0.59 < 0.59.

The bearish price targets are: 0.55 > 0.55 > 0.55.

Tweet this
Sihuan Pharmaceutical Holdings Group Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Sihuan Pharmaceutical Holdings Group Ltd. The current mas is .

The long score for the Moving Averages is 2/14.
The longshort score for the Moving Averages is -10/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Sihuan Pharmaceutical Holdings Group Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Sihuan Pharmaceutical Holdings Group Ltd. The current macd is -0.00021011.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Sihuan Pharmaceutical Holdings Group Ltd price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Sihuan Pharmaceutical Holdings Group Ltd. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Sihuan Pharmaceutical Holdings Group Ltd price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Sihuan Pharmaceutical Holdings Group Ltd Daily Moving Average Convergence/Divergence (MACD) ChartSihuan Pharmaceutical Holdings Group Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Sihuan Pharmaceutical Holdings Group Ltd. The current adx is 13.23.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Sihuan Pharmaceutical Holdings Group Ltd shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Sihuan Pharmaceutical Holdings Group Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Sihuan Pharmaceutical Holdings Group Ltd. The current sar is 0.59534272.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Sihuan Pharmaceutical Holdings Group Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Sihuan Pharmaceutical Holdings Group Ltd. The current rsi is 49.72. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
Sihuan Pharmaceutical Holdings Group Ltd Daily Relative Strength Index (RSI) ChartSihuan Pharmaceutical Holdings Group Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Sihuan Pharmaceutical Holdings Group Ltd. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Sihuan Pharmaceutical Holdings Group Ltd price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Sihuan Pharmaceutical Holdings Group Ltd Daily Stochastic Oscillator ChartSihuan Pharmaceutical Holdings Group Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Sihuan Pharmaceutical Holdings Group Ltd. The current cci is -60.4719764.

Sihuan Pharmaceutical Holdings Group Ltd Daily Commodity Channel Index (CCI) ChartSihuan Pharmaceutical Holdings Group Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Sihuan Pharmaceutical Holdings Group Ltd. The current cmo is -0.61090826.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Sihuan Pharmaceutical Holdings Group Ltd Daily Chande Momentum Oscillator (CMO) ChartSihuan Pharmaceutical Holdings Group Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Sihuan Pharmaceutical Holdings Group Ltd. The current willr is -60.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Sihuan Pharmaceutical Holdings Group Ltd is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Sihuan Pharmaceutical Holdings Group Ltd Daily Williams %R ChartSihuan Pharmaceutical Holdings Group Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Sihuan Pharmaceutical Holdings Group Ltd.

Sihuan Pharmaceutical Holdings Group Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Sihuan Pharmaceutical Holdings Group Ltd. The current atr is 0.02146594.

Sihuan Pharmaceutical Holdings Group Ltd Daily Average True Range (ATR) ChartSihuan Pharmaceutical Holdings Group Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Sihuan Pharmaceutical Holdings Group Ltd. The current obv is -623,862,552.

Sihuan Pharmaceutical Holdings Group Ltd Daily On-Balance Volume (OBV) ChartSihuan Pharmaceutical Holdings Group Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Sihuan Pharmaceutical Holdings Group Ltd. The current mfi is 44.35.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Sihuan Pharmaceutical Holdings Group Ltd Daily Money Flow Index (MFI) ChartSihuan Pharmaceutical Holdings Group Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Sihuan Pharmaceutical Holdings Group Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-06STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-08STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-09CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-10SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-13STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-16STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-20STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-21SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-11-22STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-23CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-11-29MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-01CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-04WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-06STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-12ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-14STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-18CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-20STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-22STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-27STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-28CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-09BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-11DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-16DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-17MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-19MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-23RSI LONG ENTRY SHORT CLOSE30 crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-30CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-06RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-07SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-16STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-19CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-20CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-21DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-27DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-28DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-29MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-01DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-03-05CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-06STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-07STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-14STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-19CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-20STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-22SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-25MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-03-27STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Sihuan Pharmaceutical Holdings Group Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Sihuan Pharmaceutical Holdings Group Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5049.725
Ma 20Greater thanMa 500.571
Ma 50Greater thanMa 1000.564
Ma 100Greater thanMa 2000.609
OpenGreater thanClose0.560
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Sihuan Pharmaceutical Holdings Group Ltd with someone you think should read this too:
  • Are you bullish or bearish on Sihuan Pharmaceutical Holdings Group Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Sihuan Pharmaceutical Holdings Group Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Sihuan Pharmaceutical Holdings Group Ltd

I send you an email if I find something interesting about Sihuan Pharmaceutical Holdings Group Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Sihuan Pharmaceutical Holdings Group Ltd.

Receive notifications about Sihuan Pharmaceutical Holdings Group Ltd in your mailbox!